Skip to main content
. Author manuscript; available in PMC: 2014 Nov 15.
Published in final edited form as: J Neurol Sci. 2013 Aug 2;334(0):10.1016/j.jns.2013.07.008. doi: 10.1016/j.jns.2013.07.008

Figure 2. Protein levels of SP and immune markers in CSF of subjects from HIV-NP− and HIV-NP+ groups.

Figure 2

Levels of immune markers were analyzed in CSF of HIV-1 infected subjects with (n=10) or without (n=9) HIV-associated neuropathology using flow cytometry-based Cytometric Bead Array or antigen competition enzyme immunoassay for SP. Data are expressed as log10 pg/ml. Differences between the two groups were assessed for all markers using Mann-Whitney tests.